Stock Price
4.20
Daily Change
0.14 3.45%
Monthly
6.60%
Yearly
92.66%
Q1 Forecast
4.10

Acasti Pharma reported $1.24M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Acasti Pharma USD 1.24M 1.08M Sep/2025
Addus HomeCare USD 149.49M 7.31M Dec/2025
Amarin USD 182.23M 3.71M Sep/2025
Cassava Sciences USD 48.05M 716K Sep/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Option Care Health USD 829.35M 5.44M Dec/2025
Organigram Holdings CAD 126.16M 18.88M Sep/2025
Tilray USD 280.3M 18.13M Mar/2025